Clinical Safety

Recent Phase Ib clinical data revealed that patients with recurring major depressive disorder experienced a fifty percent reduction in depression scores just eight days after beginning treatment with Zalsupindole. This remarkable finding underscores a significant pivot within the medical community

ALLO-329 Shows Rapid Benefits for Systemic Sclerosis, an experimental therapy that utilizes healthy donor cells to create an available, pre-manufactured product designed to address the high cost and logistical hurdles of cell therapy. Systemic sclerosis, a devastating autoimmune condition often

Researchers have identified that inhibiting the Wee1 protein inadvertently disables a critical switch required for all fast-proliferating cells to begin the DNA replication process. For decades, the pharmaceutical industry has focused on Wee1 as a potential vulnerability for tumors that lack the

Hospitalized cancer patients benefit from a digital safety net that ensures their emotional support and medication needs are met without being overlooked. In the fast-paced environment of a modern oncology unit, the sheer volume of tasks can become overwhelming for even the most experienced

Automated systems download requested analyses directly from internal laboratory information systems to ensure each blood sample follows the correct workflow. This technological integration has become a vital response to the critical shortage of skilled laboratory technicians facing medical

The recent bankruptcy filing of Karyopharm Therapeutics includes a restructuring support agreement and a $55 million debtor-in-possession financing package to maintain clinical operations. This development serves as a sobering reminder of the razor-thin margins for error that currently define the